Contact this trialFirst, we need to learn more about you.
Tyrosine Kinase Inhibitor
Selpercatinib for Advanced Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
Toronto, Ontario
This trial is testing a new drug for people with a certain type of lung cancer that has spread to other parts of the body. The new drug is compared to the standard treatment, and participants who stop the standard treatment due to their cancer progressing can try the new drug.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service